| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement.
Analysts estimate that Myovant Sciences will report an earnings per share (EPS) of $-0.48.
Myovant Sciences bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Last quarter the company beat EPS by $0.08, which was followed by a 8.01% increase in the share price the next day.
Here's a look at Myovant Sciences's past performance and the resulting price change:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -0.57 | -0.60 | -0.38 |
| EPS Actual | -0.22 | -0.63 | -0.68 | -0.23 |
| Price Change % | 8.01% | -13.06% | -4.98% | -1.31% |
Shares of Myovant Sciences were trading at $26.79 as of October 24. Over the last 52-week period, shares are up 36.02%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Myovant Sciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MYOV
